New cataract tool aims to protect eye cells during surgery

NCT ID NCT07176416

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new device called the Veritas Vision System for cataract surgery. The goal is to see if it uses less energy and causes less damage to the cells on the inside of the eye. Researchers will follow 50 adults for 3 months after surgery to check eye health and vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Veritas Vision System (a device for cataract surgery)
What this could lead to
If successful, this device could make cataract surgery safer by using less energy and causing less damage to the eye's inner lining.
What could go wrong
This is a small, early study with only 50 people, so results may not apply to everyone. The device may not show a clear benefit over existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aloha Vision Consultants

    RECRUITING

    ‘Aiea, Hawaii, 96701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.